PhD Alen Krajnc

PhD Alen Krajnc
no.: 55572 source: ARIS

researcher – active in research organisation
  alen.krajncat signffa.uni-lj.si
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   

Code Science Field
P390  Natural sciences and mathematics  Organic chemistry 
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
161.48
A''
10.47
A'
100.25
A1/2
108.62
CI10
475
CImax
175
h10
8
A1
0.58
A3
0
Data for the last 5 years (citations for the last 10 years) on November 11, 2025; Data for score A3 calculation refer to period 2020-2024
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 11  434  423  38.45 
Scopus 11  489  476  43.27 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
2nd cycle master's degree      GB 2017 
Doctoral degree  DPhil    GB 2021 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (100%, RD:100%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  4/1/2021  Assistant  Researcher  Assistant 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. N1-0411  Two-photon-activated targeted cancer therapies   3/1/2025 - 2/29/2028  PhD Anja Pišlar   1,299 
2. J1-60023  Boosting Our Resolve against Carbapenemase-Resistance with boron-containing therapeutics   1/1/2025 - 12/31/2027  PhD Alen Krajnc   2,287 
3. BI-VB/25-27-002  Tackling carbapenemase-mediated resistance to beta-lactam antibiotics   1/1/2025 - 12/31/2026  PhD Alen Krajnc   39 
4. BI-FR/24-25-PROTEUS-003  Antibiotic adjuvants – Translocation of novel (cyclic boron-based) β-lactamase inhibitors across OmpF/OmpC porin channels and subcellular quantification of in enterobacteria   1/1/2025 - 12/31/2025  PhD Alen Krajnc   39 
5. BI-FR/24-25-PROTEUS-003  Antibiotic adjuvants: translocation of boron-containing β-lactamase inhibitors via OmpF/OmpC porin channels and their subcellular quantification in Enterobacteria   1/1/2024 - 12/31/2025  PhD Alen Krajnc   39 
6. Z1-4405  Development of new antibiotics simultaneously targeting beta-lactamases and penicillin-binding proteins   10/1/2022 - 9/30/2024  PhD Alen Krajnc   39 
7. J4-1778  Exploitation of a virus-borne small protein to combat antibiotic resistance in Staphylococcus aureus   7/1/2019 - 12/31/2022  PhD Matej Butala   3,681 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2022 - 12/31/2027 PhD Stanislav Gobec   5,973 
2. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2015 - 12/31/2021 PhD Stanislav Gobec   6,671 
Confirmation required
Views history
Favourite